Loading your page…
Each register with its number of medicines and a few of them.
Health Canada · 4 medicines
FDA · 4 medicines
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
Anvisa · 3 medicines
SFDA · 3 medicines · Historical list
AEMPS · 2 medicines
CBG-MEB · 2 medicines
HSA · 2 medicines
AIFA · 1 medicine
ALIMS · 1 medicine
Every register, a page at a time. Strengths and packs are on each medicine’s page.
25 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Arzerra | United States | 100MG/5ML | injectable | Marketed | Novartis |
| Kesimpta | United States | 20MG/0.4ML | solution | Marketed | Novartis |
| Kesimpta | United States | 20MG/0.4ML | Injection | Marketed | Novartis Pharmaceuticals Corporation |
| Kesimpta | United States | 20MG/0.4ML | Injection | Not marketed | Novartis Pharmaceuticals Corporation |
| KESIMPTA 20 mg SOLUCION INYECTABLE EN PLUMA PRECARGADA | Spain | 20 mg | solución inyectable en pluma precargada | Marketed | Novartis Europharm Limited |
| Kesimpta | European Union | Authorised | Novartis Europharm Limited | ||
| Kesimpta 20 mg, oplossing voor injectie in voorgevulde pen | Netherlands | Oplossing voor injectie | Authorised | Novartis Europharm Limited | |
| Kesimpta 20 mg, oplossing voor injectie in voorgevulde spuit | Netherlands | Oplossing voor injectie | Authorised | Novartis Europharm Limited | |
| Kesimpta 20 MG Solucion Inyectable en Pluma Precargada | Spain | 20 mg | solución inyectable en pluma precargada | Authorised | Novartis Europharm Limited |
| Kesimpta | Italy | Soluzione iniettabile | Authorised | Novartis Europharm Limited | |
| Kesimpta | Canada | 20 MG / 0.4 ML | Solution | Marketed | Novartis Pharmaceuticals Canada INC |
| Kesimpta | Brazil | Authorised | Novartis Biociencias S.A | ||
| Kesimpta | Canada | 20 MG / 0.4 ML | Solution | Authorised | Novartis Pharmaceuticals Canada INC |
| Kesimpta® | Serbia | 20mg | rastvor za injekciju u napunjenom injekcionom penu | Authorised | PredstavniŠTvo Novartis Pharma Services INC. Beograd (Novi Beograd) |
| Kesimpta Solution for Injection in Pre-Filled Pen 20MG/0.4ML | Singapore | 20mg/0.4ml | injection, solution | Authorised | Novartis (Singapore) Pte LTD |
| Kesimpta Solution for Injection in Pre-Filled Syringe 20MG/0.4ML | Singapore | 20mg/0.4ml | injection, solution | Authorised | Novartis (Singapore) Pte LTD |
| Kesimpta | Croatia | Marketed | |||
| Arzerra | European Union | Withdrawn | Novartis Europharm Ltd | ||
| Arzerra | Saudi Arabia | Authorised | Glaxo Operation | ||
| Arzerra | Saudi Arabia | Authorised | Glaxo Operation | ||
| Kesimpta | Saudi Arabia | Authorised | NOVARTIS Pharma Stein AG | ||
| Arzerra | Canada | 1000 MG / 50 ML | Solution | Cancelled | Novartis Pharmaceuticals Canada INC |
| Arzerra | Brazil | Cancelled | Novartis Biociencias S.A | ||
| Arzerra | Brazil | Cancelled | Glaxosmithkline Brasil Ltda | ||
| Arzerra | Canada | 100 MG / 5 ML | Solution | Cancelled | Novartis Pharmaceuticals Canada INC |
The same brand on several registers.
The companies holding its medicines, the most first.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, ALIMS, Anvisa, CBG-MEB, EMA, FDA, HALMED, Health Canada, HSA and SFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
